Riverbridge Partners LLC decreased its holdings in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 10.3% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,947,871 shares of the company's stock after selling 569,799 shares during the quarter. Privia Health Group comprises approximately 1.8% of Riverbridge Partners LLC's holdings, making the stock its 14th biggest holding. Riverbridge Partners LLC owned approximately 4.06% of Privia Health Group worth $113,801,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also made changes to their positions in the company. Bessemer Group Inc. lifted its holdings in shares of Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after acquiring an additional 2,178 shares in the last quarter. Janney Montgomery Scott LLC lifted its holdings in shares of Privia Health Group by 4.6% during the 1st quarter. Janney Montgomery Scott LLC now owns 55,371 shares of the company's stock valued at $1,243,000 after acquiring an additional 2,413 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Privia Health Group by 113.1% during the 1st quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock valued at $64,000 after acquiring an additional 1,521 shares in the last quarter. Strs Ohio acquired a new position in Privia Health Group in the 1st quarter worth $849,000. Finally, Teacher Retirement System of Texas acquired a new position in Privia Health Group in the 1st quarter worth $387,000. Institutional investors and hedge funds own 94.48% of the company's stock.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on PRVA shares. Citigroup reiterated an "outperform" rating on shares of Privia Health Group in a report on Friday, August 29th. JPMorgan Chase & Co. boosted their price objective on shares of Privia Health Group from $29.00 to $32.00 and gave the stock an "overweight" rating in a report on Wednesday, May 28th. JMP Securities boosted their price objective on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a report on Friday, August 29th. Zacks Research upgraded shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. Finally, Evercore ISI cut their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $28.58.
View Our Latest Stock Report on PRVA
Privia Health Group Stock Performance
Shares of Privia Health Group stock opened at $23.34 on Thursday. The firm has a market cap of $2.86 billion, a PE ratio of 212.20, a price-to-earnings-growth ratio of 3.40 and a beta of 0.82. The firm's 50-day simple moving average is $21.39 and its 200-day simple moving average is $22.40. Privia Health Group, Inc. has a 1 year low of $16.47 and a 1 year high of $26.09.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The company had revenue of $521.15 million during the quarter, compared to analyst estimates of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business's revenue for the quarter was up 23.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.19 EPS. Privia Health Group has set its FY 2025 guidance at EPS. On average, equities analysts predict that Privia Health Group, Inc. will post 0.14 earnings per share for the current year.
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Recommended Stories
Want to see what other hedge funds are holding PRVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Privia Health Group, Inc. (NASDAQ:PRVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.